MONZA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.833
EU - Europa 3.158
AS - Asia 2.110
SA - Sud America 119
AF - Africa 14
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.249
Nazione #
US - Stati Uniti d'America 5.751
SG - Singapore 931
IT - Italia 833
DE - Germania 639
CN - Cina 586
SE - Svezia 452
IE - Irlanda 316
RU - Federazione Russa 306
HK - Hong Kong 192
GB - Regno Unito 164
VN - Vietnam 116
BR - Brasile 105
UA - Ucraina 97
CA - Canada 76
ID - Indonesia 73
IN - India 71
DK - Danimarca 70
FR - Francia 61
TR - Turchia 50
FI - Finlandia 49
AT - Austria 37
NL - Olanda 34
BE - Belgio 26
JP - Giappone 25
ES - Italia 24
KR - Corea 15
IR - Iran 11
CZ - Repubblica Ceca 10
AU - Australia 8
TW - Taiwan 7
HR - Croazia 6
RO - Romania 6
BG - Bulgaria 5
EU - Europa 5
MA - Marocco 5
PK - Pakistan 5
CH - Svizzera 4
PL - Polonia 4
PT - Portogallo 4
RS - Serbia 4
UZ - Uzbekistan 4
IQ - Iraq 3
KG - Kirghizistan 3
KZ - Kazakistan 3
SA - Arabia Saudita 3
SC - Seychelles 3
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
EG - Egitto 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
MX - Messico 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AR - Argentina 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 11.249
Città #
Ann Arbor 1.890
Singapore 636
Frankfurt am Main 457
Wilmington 367
Chandler 358
Milan 338
Woodbridge 314
Dublin 306
Ashburn 254
Dearborn 246
Fairfield 213
Hong Kong 189
Houston 180
New York 176
Santa Clara 148
Princeton 140
Nanjing 114
Jacksonville 104
Seattle 93
Boardman 90
Cambridge 65
Jakarta 64
Shanghai 63
Guangzhou 59
Dong Ket 49
Nanchang 38
Los Angeles 35
Lawrence 33
Altamura 32
Vienna 32
Shenyang 30
Pune 29
Hangzhou 27
Helsinki 26
Council Bluffs 25
Nuremberg 25
Carate Brianza 24
Beijing 23
Toronto 23
Brussels 21
Ottawa 21
Rome 21
Shangdi 21
Zhengzhou 21
Andover 19
Fremont 19
Kunming 19
San Diego 18
Dallas 17
Kocaeli 17
Sacramento 16
Falls Church 15
Tianjin 15
Jiaxing 14
Jinan 14
Chicago 13
Edmonton 13
Hebei 13
Lachine 13
Changsha 12
Lissone 12
Mainz 12
Norwalk 12
London 11
Codroipo 10
Florence 10
Melzo 10
Elche 9
Kiev 9
Sesto San Giovanni 8
Canazei 7
Hefei 7
São Paulo 7
Tokyo 7
Wuhan 7
Belo Horizonte 6
Chengdu 6
Frederick 6
Grafing 6
Induno Olona 6
Philadelphia 6
Romola 6
Taizhou 6
Bologna 5
Brno 5
Cagliari 5
Chandigarh 5
Falkenstein 5
Lanzhou 5
Madrid 5
Merate 5
Ningbo 5
Paderno Dugnano 5
Paris 5
Pavia 5
Salt Lake City 5
Villeurbanne 5
Washington 5
Zagreb 5
Cislago 4
Totale 7.937
Nome #
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 329
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 309
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 247
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 240
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 235
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 233
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 228
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 225
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 225
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 223
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 221
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 215
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 214
In vitro models for studying oxaliplatin neurotoxic effects 209
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 208
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 204
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 203
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 201
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 196
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 189
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 189
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 189
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 180
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 177
Incubation with low doses of oxaliplatin modifies the electrophysiological properties of dorsal root ganglion neurons 177
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 177
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 171
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 162
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 160
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 159
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 157
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 154
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 152
Thermal plantar test in experimental ischemic stroke 147
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 144
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 144
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 143
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 143
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 141
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 138
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 138
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 136
Multimodal experimental approach to the study of human neurological diseases 136
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 136
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 136
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 134
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 134
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 134
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 131
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 130
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 127
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 124
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 124
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 119
Pharmacokinetics of IVIg in Wistar rats 117
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 117
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 111
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 109
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 106
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 104
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 104
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 103
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 102
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 102
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 101
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 95
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 95
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 91
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 91
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 90
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 86
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 76
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 69
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 65
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 62
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 61
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 61
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 59
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 50
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 41
A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain 40
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 38
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 35
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 31
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 30
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 27
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 27
Totale 12.093
Categoria #
all - tutte 44.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020278 0 0 0 0 0 0 0 0 0 148 110 20
2020/20212.161 48 59 222 210 155 226 249 254 179 160 161 238
2021/20221.207 122 164 133 116 84 96 60 54 49 63 84 182
2022/20231.828 198 362 223 187 155 304 58 84 120 31 64 42
2023/20241.293 56 46 59 76 144 292 191 75 63 32 40 219
2024/20252.457 163 470 343 160 320 141 300 138 422 0 0 0
Totale 12.093